Skip to main content

Clover Health Investments, Corp.

corporate_fare Company Profile

Clover Health Investments, Corp.

CLOV·NASDAQ·Finance·CIK 0001801170

Clover Health aims to empower physicians with technology to identify, manage, and treat chronic diseases earlier, leading to earlier diagnosis and treatment, earlier disease management, and more affordable and accessible care. The company's strategy involves improving care for its Medicare Advantage ("MA") members, developing extensive physician networks, and providing technology to support physicians. Its proprietary software platform, Clover Assistant, also licensed externally as Counterpart Assistant, supports real-time clinical decision-making at the point of care by providing clinicians with data and insights. This cloud-based software platform curates data from over 100 sources, offering physicians access to data-driven insights and personalized care recommendations for patients. Provider use of Clover Assistant enables data-driven clinical decision-making, benefiting members and driving rapid software iteration. The more providers use Clover Assistant, the more it learns and refines the precision of personalized data-driven recommendations. Clover Health combines beneficiary data with provider-generated data, using this feedback loop to continuously fine-tune its proprietary clinical rules and machine learning models, and to prioritize future software capabilities.

Clover Health Investments, Corp. (NASDAQ:CLOV) is a publicly traded company in the Finance sector. Wiseek has independently scored 26 items for CLOV at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Clover Health Goes Live on Kno2 for Real-Time Patient Data Access, Advancing Federal Interoperability
  • Clover Health Reaffirms 2026 GAAP Net Income Profitability Goal, Details Strategic Drivers
  • Clover Health Reports Increased Net Loss and Negative Operating Cash Flow for 2025 Despite Revenue Growth
  • Clover Health Projects First-Ever GAAP Net Income Profitability in 2026 Amidst Strong Growth
  • Clover Health Forecasts First-Ever GAAP Net Income Profitability in 2026 Amidst 53% Medicare Advantage Membership Growth

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.92B
Net Income
-$85.55M
Op. Cash Flow
-$66.93M
Free Cash Flow
-$68.98M
Operating Income
-$85.53M
Cash & Equivalents
$78.3M
Debt / Equity
0.00×
Net Margin
-4.4%
Shares Outstanding
511.97M sh
Source: 10-K · filed 2026-02-27 · accession 0001801170-26-000057
$3.75 +0.57% today
52-week range · as of 2026-11-06 $1.58 – $5.59
Market cap
$1.98B
Volume
7.3M (1.5× avg)
3-mo avg 4.8M
Live data · 2026-11-22 12:44 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CLOV - Filings & News (Page 2)

CLOV
Mar 10, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.99
Real-time Price: $3.75 info
Change: +$1.76 (+88%) info
Market Cap: $1.981B info
CLOV
Mar 06, 2026, 9:06 AM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $2.05
Real-time Price: $3.75 info
Change: +$1.70 (+83%) info
Market Cap: $1.981B info
CLOV
Feb 27, 2026, 8:08 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $2.09
Real-time Price: $3.75 info
Change: +$1.66 (+79%) info
Market Cap: $1.981B info
CLOV
Feb 26, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.22
Real-time Price: $3.75 info
Change: +$1.53 (+69%) info
Market Cap: $1.981B info
CLOV
Jan 14, 2026, 8:32 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.54
Real-time Price: $3.75 info
Change: +$1.21 (+48%) info
Market Cap: $1.981B info
CLOV
Jan 09, 2026, 4:08 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $2.60
Real-time Price: $3.75 info
Change: +$1.15 (+44%) info
Market Cap: $1.981B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets